Kerry S. Campbell

2024

Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT

Wasserman, J. S., Fowle, H., Hashmi, R., Atar, D., Patel, K., Yarmahmoodi, A., Macfarlane, A. W., Tan, Y., Cukierman, E., Gligorijevic, B., Karami, A., Whelan, K. A., Campbell, K. S. & Graña, X., Apr 6 2024, (Research square).

Research output: Working paper › Preprint

Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT

Wasserman, J. S., Fowle, H., Hashmi, R., Atar, D., Patel, K. R., Yarmahmoodi, A., Macfarlane, A. W., Tan, Y., Cukierman, E., Gligorijevic, B., Karami, A., Whelan, K. A., Campbell, K. S. & Graña, X., Aug 2 2024, In: Scientific Reports. 14, 1, 20409.

Research output: Contribution to journal › Article › peer-review

Open Access

Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer

Vendramini-Costa, D. B., Francescone, R., Franco-Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N., Gardiner, J. C., Dos Santos, S. A. A., Ogier, C., Malloy, E., Borghaei, L., Martinez, E., Zhigarev, D. I., Tan, Y., Lee, H., Zhou, Y., Cai, K. Q., Klein-Szanto, A. J. & Wang, H. & 4 others, Andrake, M., Dunbrack, R. L., Campbell, K. & Cukierman, E., Apr 18 2024, (bioRxiv).

Research output: Working paper › Preprint

Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer

Murayama, T., Nakayama, J., Jiang, X., Miyata, K., Morris, A. D., Cai, K. Q., Prasad, R. M., Ma, X., Efimov, A., Belani, N., Gerstein, E. R., Tan, Y., Zhou, Y., Kim, W., Maruyama, R., Campbell, K. S., Chen, L., Yang, Y., Balachandran, S. & Canadas, I., 2024, In: Cancer Discovery. 14, 3, p. 468-491 24 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing

Maskalenko, N. A., Zahroun, S., Tsygankova, O., Anikeeva, N., Sykulev, Y. & Campbell, K. S., Nov 12 2024, (E-pub ahead of print) In: Cancer Immunology Research.

Research output: Contribution to journal › Article › peer-review

2023

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

Zibelman, M., MacFarlane, A. W., Costello, K., McGowan, T., O’Neill, J., Kokate, R., Borghaei, H., Denlinger, C. S., Dotan, E., Geynisman, D. M., Jain, A., Martin, L., Obeid, E., Devarajan, K., Ruth, K., Alpaugh, R. K., Dulaimi, E. A. S., Cukierman, E., Einarson, M. & Campbell, K. S. & 1 others, Plimack, E. R., Jun 27 2023, In: Nature Communications. 14, 1, p. 4513 4513.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Jang, H. J., Hostetter, G., MacFarlane, A. W., Madaj, Z., Ross, E. A., Hinoue, T., Kulchycki, J. R., Burgos, R. S., Tafseer, M., Alpaugh, R. K., Schwebel, C. L., Kokate, R., Geynisman, D. M., Zibelman, M. R., Ghatalia, P., Nichols, P. W., Chung, W., Madzo, J., Hahn, N. & Quinn, D. I. & 7 others, Issa, J. P., Topper, M., Baylin, S. B., Shen, H., Campbell, K. S., Jones, P. A. & Plimack, E. R., Jun 1 2023, In: Clinical Cancer Research. 29, 11, p. 2052-2065 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

Murine Cytomegalovirus Encodes a Specific Cell Surface Marker That Can Trigger Attack by NK Cells

Campbell, K. S., Mar 1 2023, In: Journal of Immunology. 210, 5, p. 519-520 2 p.

Research output: Contribution to journal › Article › peer-review

Open Access

TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype

Tricarico, R., Madzo, J., Scher, G., Cohen, M., Jelinek, J., Maegawa, S., Nagarathinam, R., Scher, C., Chang, W. C., Nicolas, E., Slifker, M., Zhou, Y., Devarajan, K., Cai, K. Q., Kwok, T., Nakajima, P., Xu, J., Mancuso, P., Doneddu, V. & Bagella, L. & 21 others, Williams, R., Balachandran, S., Maskalenko, N., Campbell, K., Ma, X., Cañadas, I., Viana-Errasti, J., Moreno, V., Valle, L., Grivennikov, S., Peshkova, I., Kurilenko, N., Mazitova, A., Koltsova, E., Lee, H., Walsh, M., Duttweiler, R., Whetstine, J. R., Yen, T. J., Issa, J. P. & Bellacosa, A., May 2023, In: Gastroenterology. 164, 6, p. 921-936.e1

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells

Richardson, K., Keam, S. P., Zhu, J. J., Meyran, D., D’Souza, C., Macdonald, S., Campbell, K., Robbins, M., Bezman, N. A., Todd, K., Quach, H., Ritchie, D. S., Harrison, S. J., Prince, H. M., Trapani, J. A., Jenkins, M. R., Beavis, P. A., Darcy, P. K. & Neeson, P. J., Jan 2023, In: Haematologica. 108, 1, p. 83-97 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

2022

Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma

Iraqi, M., Edri, A., Greenshpan, Y., Goldstein, O., Ofir, N., Bolel, P., Ahmad, M. A., Zektser, M., Campbell, K. S., Rouvio, O., Gazit, R. & Porgador, A., Apr 2022, In: International Journal of Molecular Sciences. 23, 9, 4717.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient

Valentine, H., Aiken, W., Morrison, B., Zhao, Z., Fowle, H., Wasserman, J. S., Thompson, E., Chin, W., Young, M., Clarke, S., Gibbs, D., Harrison, S., McLaughlin, W., Kwok, T., Jin, F., Campbell, K. S., Horvath, A., Thompson, R., Lee, N. H. & Zhou, Y. & 3 others, Graña, X., Ragin, C. & Badal, S., 2022, In: Cancer Res Commun. 2, 11, p. 1355-1371 17 p.

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders

Maskalenko, N. A., Zhigarev, D. & Campbell, K. S., Aug 2022, In: Nature Reviews Drug Discovery. 21, 8, p. 559-577 19 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

119 Scopus citations

IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma

Aghayev, T., Mazitova, A. M., Fang, J. R., Peshkova, I. O., Rausch, M., Hung, M., White, K. F., Masia, R., Titerina, E. K., Fatkhullina, A. R., Cousineau, I., Turcotte, S., Zhigarev, D., Marchenko, A., Khoziainova, S., Makhov, P., Tan, Y. F., Kossenkov, A. V., Wiest, D. L. & Stagg, J. & 7 others, Wang, X. W., Campbell, K. S., Dzutsev, A. K., Trinchieri, G., Hill, J. A., Grivennikov, S. I. & Koltsova, E. K., Aug 1 2022, In: Cancer Discovery. 12, 8, p. 1960-1983 24 p.

Research output: Contribution to journal › Article › peer-review

Open Access

21 Scopus citations

Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology

Zhigarev, D., Varshavsky, A., MacFarlane, A. W., Jayaguru, P., Barreyro, L., Khoreva, M., Dulaimi, E., Nejati, R., Drenberg, C. & Campbell, K. S., Jun 10 2022, In: Cancers. 14, 14, 3352.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma

Campbell, K. S., Ford, J. W., Gonzalez-Cotto, M., MacFarlane, A. W., Peri, S., Howard, O. M. Z., Subleski, J. J., Ruth, K., Haseebuddin, M., Al-Saleem, T., Yang, Y., Rayman, P., Rini, B. I., Linehan, W. M., Finke, J., Weiss, J. M. & McVicar, D. W., Feb 10 2022, In: Frontiers in Oncology. 11, p. 662723 662723.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

2021

Alterations of nk cell phenotype in the disease course of multiple myeloma

Pazina, T., Macfarlane, A. W., Bernabei, L., Dulaimi, E., Kotcher, R., Yam, C., Bezman, N. A., Robbins, M. D., Ross, E. A., Campbell, K. S. & Cohen, A. D., Jan 2 2021, In: Cancers. 13, 2, p. 1-22 22 p., 226.

Research output: Contribution to journal › Article › peer-review

Open Access

45 Scopus citations

Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms

MacFarlane, A. W., Yeung, H. M., Alpaugh, R. K., Dulaimi, E., Engstrom, P. F., Dasari, A. N., Campbell, K. S. & Vijayvergia, N., Jul 2021, In: Cancer Immunology, Immunotherapy. 70, 7, p. 1893-1906 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Mystery checkpoint revealed: KIR3DL3 finally found a ligand in HHLA2

Campbell, K. S., Feb 1 2021, In: Cancer Immunology Research. 9, 2, p. 128 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

11 Scopus citations

Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast–driven nutritional support and immunosuppression

Francescone, R., Vendramini-Costa, D. B., Franco-Barraza, J., Wagner, J., Muir, A., Lau, A. N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., Rollins, D., Malik, R., Thapa, R. J., Restifo, D., Zhou, Y., Cai, K. Q., Hensley, H. H., Tan, Y., Kruger, W. D. & Devarajan, K. & 9 others, Balachandran, S., Klein-Szanto, A. J., Wang, H., El-Deiry, W. S., Vander Heiden, M. G., Peri, S., Campbell, K. S., Astsaturov, I. & Cukierman, E., 2021, In: Cancer Discovery. 11, 2, p. 446-479 34 p.

Research output: Contribution to journal › Article › peer-review

Open Access

125 Scopus citations

Novel protein‐based vaccine against self‐antigen reduces the formation of sporadic colon adenomas in mice

Belnoue, E., Leystra, A. A., Carboni, S., Cooper, H. S., Macedo, R. T., Harvey, K. N., Colby, K. B., Campbell, K. S., Vanderveer, L. A., Clapper, M. L. & Derouazi, M., Feb 2021, In: Cancers. 13, 4, p. 1-16 16 p., 845.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Анализ субпопуляций лимфоцитов костного мозга больных острым миелоидным лейкозом: иммунологические эффекты химиотерапии

Translated title of the contribution: Analysis of subpopulations of bone marrow lymphocytes in patients with acute myeloid leukemia: Immunological effects of chemotherapyZhigarev, D. I., Khoreva, M. V., Campbell, K. S. & Gankovskaya, L. V., 2021, In: Immunologiya. 42, 4, p. 364-375 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2020

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer

Fernandez, S. V., MacFarlane, A. W., Jillab, M., Arisi, M. F., Yearley, J., Annamalai, L., Gong, Y., Cai, K. Q., Alpaugh, R. K., Cristofanilli, M. & Campbell, K. S., Nov 2 2020, In: Breast Cancer Research. 22, 1, p. 134 134.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection

Zhou, L., Huntington, K., Zhang, S., Carlsen, L., So, E. Y., Parker, C., Sahin, I., Safran, H., Kamle, S., Lee, C. M., Lee, C. G., Elias, J. A., Campbell, K. S., Naik, M. T., Atwood, W. J., Youssef, E., Pachter, J. A., Navaraj, A., Seyhan, A. A. & Liang, O. & 1 others, El-Deiry, W. S., Nov 2020, In: Oncotarget. 11, 46, p. 4201-4223 23 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic

Ralff, M. D., Jhaveri, A., Ray, J. E., Zhou, L., Lev, A., Campbell, K. S., Dicker, D. T., Ross, E. A. & El-Deiry, W. S., Oct 20 2020, In: Oncotarget. 11, 42, p. 3753-3769 17 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

2019

Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2

Cheng, H., Schwell, V., Curtis, B. R., Fazlieva, R., Roder, H. & Campbell, K. S., Apr 2 2019, In: Structure. 27, 4, p. 639-650.e2

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma

Pazina, T., James, A. M., Colby, K. B., Yang, Y., Gale, A., Jhatakia, A., Kearney, A. Y., Graziano, R. F., Bezman, N. A., Robbins, M. D., Cohen, A. D. & Campbell, K. S., 2019, In: Cancer Immunology Research. 7, 10, p. 1633-1646 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

32 Scopus citations

Inhibition of the NKp44-PCNA immune checkpoint using a MAb to PCNA

Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J. C., Lazar, V., Joshua, B. Z., Campbell, K. S., Elkabets, M. & Porgador, A., 2019, In: Cancer Immunology Research. 7, 7, p. 1120-1134 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects

Banerjee, P. P., Pang, L., Soldan, S. S., Miah, S. M., Eisenberg, A., Maru, S., Waldman, A., Smith, E. A., Rosenberg-Hasson, Y., Hirschberg, D., Smith, A., Ablashi, D. V., Campbell, K. S. & Orange, J. S., Nov 2019, In: Molecular Immunology. 115, p. 39-55 17 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma

Barta, S. K., Zain, J., MacFarlane, A. W., Smith, S. M., Ruan, J., Fung, H. C., Tan, C. R., Yang, Y., Alpaugh, R. K., Dulaimi, E., Ross, E. A., Campbell, K. S., Khan, N., Siddharta, R., Fowler, N. H., Fisher, R. I. & Oki, Y., Jun 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19, 6, p. 356-364.e3

Research output: Contribution to journal › Article › peer-review

Open Access

108 Scopus citations

The need for cell lines from diverse ethnic backgrounds for prostate cancer research

Badal, S., Campbell, K. S., Valentine, H. & Ragin, C., Dec 1 2019, In: Nature Reviews Urology. 16, 12, p. 691-692 2 p.

Research output: Contribution to journal › Comment/debate

Open Access

12 Scopus citations

2018

Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment

Wagner, J., Kline, C. L. B., Zhou, L., Campbell, K. S., MacFarlane, A. W., Olszanski, A. J., Cai, K. Q., Hensley, H., Ross, E. A., Ralff, M. D., Zloza, A., Chesson, C. B., Newman, J. H., Kaufman, H., Bertino, J., Stein, M. & El-Deiry, W. S., May 1 2018, In: Journal of Clinical Investigation. 128, 6, p. 2325-2338 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

55 Scopus citations

In vitro evidence that combination therapy with CD16-bearing NK-92 cells and FDA-approved alefacept can selectively target the latent HIV reservoir in CD4+ CD2hi memory T cells

Tomalka, A. G., Resto-Garay, I., Campbell, K. S. & Popkin, D. L., Nov 5 2018, In: Frontiers in Immunology. 9, NOV, p. 2552 2552.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Scopus citations

Mechanisms of NK cell activation and clinical activity of the therapeutic SLAMF7 antibody, elotuzumab in multiple myeloma

Campbell, K. S., Cohen, A. D. & Pazina, T., Nov 5 2018, In: Frontiers in Immunology. 9, NOV, p. 2551 2551.

Research output: Contribution to journal › Review article › peer-review

Open Access

89 Scopus citations

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints

Shemesh, A., Brusilovsky, M., Kundu, K., Ottolenghi, A., Campbell, K. S. & Porgador, A., Dec 1 2018, In: Cancer Immunology, Immunotherapy. 67, 12, p. 1871-1883 13 p.

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

2017

Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures

Finnberg, N. K., Gokare, P., Lev, A., Grivennikov, S. I., MacFarlane, A. W., Campbell, K. S., Winters, R. M., Kaputa, K., Farma, J. M., Abbas, A. E. S., Grasso, L., Nicolaides, N. C. & El-Deiry, W. S., Sep 15 2017, In: Oncotarget. 8, 40, p. 66747-66757 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

97 Scopus citations

Expression of NKp46 splice variants in nasal lavage following respiratory viral infection: Domain 1-negative isoforms predominate and manifest higher activity

Shemer-Avni, Y., Kundu, K., Shemesh, A., Brusilovsky, M., Yossef, R., Meshesha, M., Solomon-Alemayehu, S., Levin, S., Gershoni-Yahalom, O., Campbell, K. S. & Porgador, A., Feb 15 2017, In: Frontiers in Immunology. 8, FEB, p. 161 161.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

Haploinsufficiency in tumor predisposition syndromes: Altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation

Peri, S., Caretti, E., Tricarico, R., Devarajan, K., Cheung, M., Sementino, E., Menges, C. W., Nicolas, E., Vanderveer, L. A., Howard, S., Conrad, P., Crowell, J. A., Campbell, K. S., Ross, E. A., Godwin, A. K., Yeung, A. T., Clapper, M. L., Uzzo, R. G., Henske, E. P. & Ricketts, C. J. & 6 others, Vocke, C. D., Marston Linehan, W., Testa, J. R., Bellacosa, A., Kopelovich, L. & Knudson, A. G., 2017, In: Oncotarget. 8, 11, p. 17628-17642 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

MacFarlane, A. W., Jillab, M., Smith, M. R., Alpaugh, R. K., Cole, M., Litwin, S., Millenson, M. M., Al-Saleem, T., Cohen, A. D. & Campbell, K. S., Jul 3 2017, In: OncoImmunology. 6, 7, p. e1330235 e1330235.

Research output: Contribution to journal › Article › peer-review

Open Access

52 Scopus citations

Regulation of the functions of natural cytotoxicity receptors by interactions with diverse ligands and alterations in splice variant expression

Pazina, T., Shemesh, A., Brusilovsky, M., Porgador, A. & Campbell, K. S., Mar 30 2017, In: Frontiers in Immunology. 8, MAR, p. 369 369.

Research output: Contribution to journal › Review article › peer-review

Open Access

75 Scopus citations

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

Bobrov, E., Skobeleva, N., Restifo, D., Beglyarova, N., Cai, K. Q., Handorf, E., Campbell, K., Proia, D. A., Khazak, V., Golemis, E. A. & Astsaturov, I., 2017, In: Oncotarget. 8, 3, p. 4399-4409 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms

Pazina, T., James, A. M., MacFarlane, A. W., Bezman, N. A., Henning, K. A., Bee, C., Graziano, R. F., Robbins, M. D., Cohen, A. D. & Campbell, K. S., Sep 2 2017, In: OncoImmunology. 6, 9, p. e1339853 e1339853.

Research output: Contribution to journal › Article › peer-review

Open Access

64 Scopus citations

2016

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells

Davis, Z. B., Cogswell, A., Scott, H., Mertsching, A., Boucau, J., Wambua, D., Le Gall, S., Planelles, V., Campbell, K. S. & Barker, E., Feb 2016, In: PLoS Pathogens. 12, 2, p. e1005421 e1005421.

Research output: Contribution to journal › Article › peer-review

Open Access

61 Scopus citations

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

Jochems, C., Hodge, J. W., Fantini, M., Fujii, R., Morillon, Y. M., Greiner, J. W., Padget, M. R., Tritsch, S. R., Tsang, K. Y., Campbell, K. S., Klingemann, H., Boissel, L., Rabizadeh, S., Soon-Shiong, P. & Schlom, J., Nov 27 2016, In: Oncotarget. 7, 52, p. 86359-86373 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

151 Scopus citations

Cutting edge: Role of NK cells and surfactant protein D in dendritic cell lymph node homing: Effects of ozone exposure

Ge, M. Q., Kokalari, B., Flayer, C. H., Killingbeck, S. S., Redai, I. G., MacFarlane, A. W., Hwang, J. W., Kolupoti, A., Kemeny, M. D., Campbell, K. S. & Haczku, A., Jan 15 2016, In: Journal of Immunology. 196, 2, p. 553-557 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

Erratum: Cutting edge: Role of NK cells and surfactant protein D in dendritic cell lymph node homing: Effects of ozone exposure (Journal of Immunology (2016) 196 (553-557))

Ge, M. Q., Kokalari, B., Flayer, C. H., Killingbeck, S. S., Redai, I. G., MacFarlane, A. W., Hwang, J. W., Kolupoti, A., Kemeny, M. D., Campbell, K. S. & Haczku, A., Apr 1 2016, In: Journal of Immunology. 196, 7, p. 3212 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

4 Scopus citations

MTOR-dependent and independent survival signaling by PI3K in B lymphocytes

Kaileh, M., Vazquez, E., MacFarlane, A. W., Campbell, K., Kurosaki, T., Siebenlist, U. & Sen, R., Jan 1 2016, In: PLoS ONE. 11, 1, p. e0146955 e0146955.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: A comparative viewpoint

Shemesh, A., Kugel, A., Steiner, N., Yezersky, M., Tirosh, D., Edri, A., Teltsh, O., Rosental, B., Sheiner, E., Rubin, E., Campbell, K. S. & Porgador, A., 2016, In: Oncotarget. 7, 43, p. 70912-70923 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

Suppressing the killer instinct

Campbell, K. S., May 24 2016, In: Science Signaling. 9, 429, p. fs8 fs8.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Survival in acute myeloid leukemia is associated with NKp44 splice variants

Shemesh, A., Brusilovsky, M., Hadad, U., Teltsh, O., Edri, A., Rubin, E., Campbell, K. S., Rosental, B. & Porgador, A., May 31 2016, In: Oncotarget. 7, 22, p. 32933-32945 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

25 Scopus citations

Kerry S. Campbell, PhD

Research output

Search results